Merck & Co., Inc.MRKNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +6.79% | -1.56% | -1.90% | +3.72% | +4.97% |
| Gross Profit Growth | +10.06% | -1.02% | -0.95% | +6.71% | +28.89% |
| EBITDA Growth | +0.00% | +5.15% | -13.76% | +46.74% | -23.77% |
| Operating Income Growth | +0.00% | +3.07% | -9.40% | +64.51% | +100.92% |
| Net Income Growth | +0.00% | +6.66% | -18.85% | +83.24% | -20.84% |
| EPS Growth | +0.00% | +7.45% | -17.67% | +85.60% | -19.59% |
| EPS Diluted Growth | +0.00% | +7.49% | -17.76% | +87.10% | -19.59% |
| Weighted Average Shares Growth | -0.52% | -0.67% | -1.22% | -1.69% | -2.01% |
| Weighted Average Shares Diluted Growth | -0.52% | -0.51% | -1.22% | -1.69% | -2.09% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1302.44% | -19.09% | -41.58% | -15.81% | -100.00% |
| Free Cash Flow Growth | +0.00% | -47.42% | -47.81% | -19.66% | -100.00% |
| Receivables Growth | -0.69% | -5.07% | +1.75% | +6.49% | +23.36% |
| Inventory Growth | -3.92% | -4.82% | +2.04% | +3.20% | -100.00% |
| Asset Growth | +9.78% | +8.76% | +4.34% | +10.22% | -20.81% |
| Book Value per Share Growth | +23.87% | +20.55% | +13.80% | +18.52% | +15.92% |
| Debt Growth | +5.52% | +1.83% | -6.31% | +8.50% | +32.05% |
| R&D Expense Growth | -52.38% | -9.29% | +15.66% | -27.77% | -19.46% |
| SG&A Expenses Growth | +1.89% | +2.78% | -3.29% | -3.59% | +3.16% |